(Q48285810)

10 February 2018

title

Delayed behavioral effects following intrahippocampal injection of aggregated A beta (1-42). (English)

1 reference

10 February 2018

author name string

O'Hare E

1

1 reference

10 February 2018

Weldon DT

2

1 reference

10 February 2018

Mantyh PW

3

1 reference

10 February 2018

Ghilardi JR

4

1 reference

10 February 2018

Finke MP

5

1 reference

10 February 2018

Kuskowski MA

6

1 reference

10 February 2018

Maggio JE

7

1 reference

10 February 2018

Shephard RA

8

1 reference

10 February 2018

Cleary J

9

1 reference

10 February 2018

language of work or name

English

0 references

publication date

1 January 1999

1 reference

10 February 2018

published in

Brain Research

1 reference

10 February 2018

volume

815

1 reference

10 February 2018

page(s)

1-10

1 reference

10 February 2018

issue

1

1 reference

10 February 2018

β-Amyloid stimulates glial cells in vitro to produce growth factors that accumulate in senile plaques in Alzheimer's disease

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901002-6

beta-amyloid fibrils induce tau phosphorylation and loss of microtubule binding.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901002-6

Methodological variables in the assessment of beta amyloid neurotoxicity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901002-6

beta-Amyloid of Alzheimer's disease induces reactive gliosis that inhibits axonal outgrowth.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901002-6

Beta-amyloid(1-40) effects on behavior and memory.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901002-6

Regional cortical dysfunction in Alzheimer's disease as determined by positron emission tomography

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901002-6

The neurochemical and behavioral effects of beta-amyloid peptide(25-35)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901002-6

Mutation of the beta-amyloid precursor protein in familial Alzheimer's disease increases beta-protein production

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901002-6

A potential role for apoptosis in neurodegeneration and Alzheimer's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901002-6

Image analysis of beta-amyloid load in Alzheimer's disease and relation to dementia severity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901002-6

In vitro aggregation facilities beta-amyloid peptide-(25-35)-induced amnesia in the rat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901002-6

Microglia and cytokines in neurological disease, with special reference to AIDS and Alzheimer's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901002-6

Bilateral injections of beta A(25-35) + IBO into the hippocampus disrupts acquisition of spatial learning in the rat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901002-6

Glial fibrillary acidic protein and Alzheimer-type senile dementia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901002-6

A beta deposition inhibitor screen using synthetic amyloid.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901002-6

Decreased feeding associated with acute hypoxia in rats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901002-6

Cholecystokinin, diet palatability, and feeding regulation in rats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901002-6

The post-reinforcement pause

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901002-6

Amnestic effects in mice of four synthetic peptides homologous to amyloid beta protein from patients with Alzheimer disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901002-6

Effects of injected Alzheimer beta-amyloid cores in rat brain.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901002-6

Rodent models of Alzheimer's disease: rat A beta infusion approaches to amyloid deposits

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901002-6

Alzheimer-type neuropathology in transgenic mice overexpressing V717F β-amyloid precursor protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901002-6

Down patients: extracellular preamyloid deposits precede neuritic degeneration and senile plaques.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901002-6

Differential effects of amyloid peptides beta-(1-40) and beta-(25-35) injections into the rat nucleus basalis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901002-6

Alzheimer's disease and Down's syndrome: Sharing of a unique cerebrovascular amyloid fibril protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901002-6

Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901002-6

Characterization and chromosomal localization of a cDNA encoding brain amyloid of Alzheimer's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901002-6

Demonstration of microglial cells in and around senile (neuritic) plaques in the Alzheimer brain. An immunohistochemical study using a novel monoclonal antibody

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901002-6

An immunohistochemical quantification of fibrous astrocytes in the aging human cerebral cortex

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901002-6

7 January 2021

Astroglia in CNS injury

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901002-6

Regional differences in reactive gliosis induced by substrate-bound beta-amyloid

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901002-6

Aggregation state and neurotoxic properties of Alzheimer beta-amyloid peptide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901002-6

Correlative Memory Deficits, Abeta Elevation, and Amyloid Plaques in Transgenic Mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901002-6

Relationship of microglia and astrocytes to amyloid deposits of Alzheimer disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901002-6

The carboxy terminus of the beta amyloid protein is critical for the seeding of amyloid formation: implications for the pathogenesis of Alzheimer's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901002-6

The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901002-6

An in vivo model for the neurodegenerative effects of beta amyloid and protection by substance P

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901002-6

In vivo neurotoxicity of beta-amyloid [beta(1-40)] and the beta(25-35) fragment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901002-6

Beta-amyloid neurotoxicity requires fibril formation and is inhibited by congo red.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901002-6

Effect of beta amyloid peptides on neurons in hippocampal slice cultures

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901002-6

The topography of plaques and tangles in Down's syndrome patients of different ages

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901002-6

Calcium-destabilizing and neurodegenerative effects of aggregated beta-amyloid peptide are attenuated by basic FGF.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901002-6

Amnesia induced in mice by centrally administered beta-amyloid peptides involves cholinergic dysfunction.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901002-6

beta-Amyloid peptide in vitro toxicity: lot-to-lot variability

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901002-6

Effects of an exogenous beta-amyloid peptide on retention for spatial learning.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901002-6

Reversal of beta-amyloid-induced retention deficit after exposure to training and state cues.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901002-6

Memory impairment and neuronal dysfunction induced by beta-amyloid protein in rats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901002-6

The neuroanatomy of Alzheimer's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901002-6

Neurodegeneration induced by beta-amyloid peptides in vitro: the role of peptide assembly state

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901002-6

Beta-amyloid-induced changes in cultured astrocytes parallel reactive astrocytosis associated with senile plaques in Alzheimer's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901002-6

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901002-6

The effect of small sequential changes in fixed-ratio size upon the post-reinforcement pause

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901002-6

Beta-amyloid from Alzheimer disease brains inhibits sprouting and survival of sympathetic neurons.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901002-6

Amyloid A4 protein and its precursor in Down's syndrome and Alzheimer's disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901002-6

Alzheimer's disease: a central role for amyloid

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901002-6

Microglial interleukin-1 alpha expression in brain regions in Alzheimer's disease: correlation with neuritic plaque distribution.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901002-6

beta-Amyloid 25-35 and/or quinolinic acid injections into the basal forebrain of young male Fischer-344 rats: behavioral, neurochemical and histological effects.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901002-6

Bilateral injections of amyloid-beta 25-35 into the amygdala of young Fischer rats: behavioral, neurochemical, and time dependent histopathological effects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901002-6

Local and distant histopathological effects of unilateral amyloid-beta 25-35 injections into the amygdala of young F344 rats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901002-6

An important role of heparan sulfate proteoglycan (Perlecan) in a model system for the deposition and persistence of fibrillar A beta-amyloid in rat brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901002-6

Disruption of circadian regulation by brain grafts that overexpress Alzheimer beta/A4 amyloid

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901002-6

Alternating lever cyclic-ratio schedule analysis of the effects of atropine sulfate.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901002-6

Fibrillar beta-amyloid induces microglial phagocytosis, expression of inducible nitric oxide synthase, and loss of a select population of neurons in the rat CNS in vivo.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901002-6

Lack of long-term effects after beta-amyloid protein injections in rat brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901002-6

Occurrence of neuropathological changes and dementia of Alzheimer's disease in Down's syndrome.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901002-6

Nerve growth factor potentiates the neurotoxicity of beta amyloid

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901002-6

Neurotoxicity of a fragment of the amyloid precursor associated with Alzheimer's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901002-6

Neurotrophic and neurotoxic effects of amyloid beta protein: reversal by tachykinin neuropeptides

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901002-6

Neuroimmune mechanisms in Alzheimer disease pathogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901002-6

inferred from DOI database lookup

7 January 2021

based on heuristic

Operant regulation of feeding: a static analysis.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901002-6

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0006-8993(98)01002-6

1 reference

10 February 2018

PubMed ID

9974116

1 reference

10 February 2018